Philips WE-TRUST stroke trial surpasses 320 patients enrolled

• Philips’ sponsored WE-TRUST stroke trial surpassed 320 patients across multiple countries, reaching an enrollment milestone announced Oct. 14, 2026.
• The randomized study compares direct-to-angio-suite care with conventional imaging-first treatment for eligible patients with acute ischemic stroke caused by large-vessel occlusion.
• The streamlined pathway combines imaging with potential treatment, aiming to reduce delays and improve recovery and independence.
• WE-TRUST results remain pending; earlier single-center studies suggested the approach could shorten time to treatment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royal Philips NV published the original content used to generate this news brief on October 14, 2026, and is solely responsible for the information contained therein.